128 related articles for article (PubMed ID: 32142840)
1. Prediction of seriniquinone-drug interactions by in vitro inhibition of human cytochrome P450 enzymes.
Moreira da Silva R; Carrão DB; Habenschus MD; Jimenez PC; Lopes NP; Fenical W; Costa-Lotufo LV; de Oliveira ARM
Toxicol In Vitro; 2020 Jun; 65():104820. PubMed ID: 32142840
[TBL] [Abstract][Full Text] [Related]
2. Flavokawain A inhibits Cytochrome P450 in in vitro metabolic and inhibitory investigations.
Niu L; Ding L; Lu C; Zuo F; Yao K; Xu S; Li W; Yang D; Xu X
J Ethnopharmacol; 2016 Sep; 191():350-359. PubMed ID: 27318274
[TBL] [Abstract][Full Text] [Related]
3. Human liver microsomes study on the inhibitory effect of plantainoside D on the activity of cytochrome P450 activity.
Zhou J; Qian X; Zhou Y; Xiong S; Ji S; Wang Y; Zhao P
BMC Complement Med Ther; 2022 Jul; 22(1):197. PubMed ID: 35870998
[TBL] [Abstract][Full Text] [Related]
4. In vitro metabolism of the calmodulin antagonist DY-9760e (3-[2-[4-(3-chloro-2-methylphenyl)-1-piperazinyl]ethyl]-5,6-dimethoxy-1-(4-imidazolylmethyl)-1H-indazole dihydrochloride 3.5 hydrate) by human liver microsomes: involvement of cytochromes p450 in atypical kinetics and potential drug interactions.
Tachibana S; Fujimaki Y; Yokoyama H; Okazaki O; Sudo K
Drug Metab Dispos; 2005 Nov; 33(11):1628-36. PubMed ID: 16049129
[TBL] [Abstract][Full Text] [Related]
5. Metabolic interactions of magnolol with cytochrome P450 enzymes: uncompetitive inhibition of CYP1A and competitive inhibition of CYP2C.
Kim SB; Kang HE; Cho HJ; Kim YS; Chung SJ; Yoon IS; Kim DD
Drug Dev Ind Pharm; 2016; 42(2):263-9. PubMed ID: 26133083
[TBL] [Abstract][Full Text] [Related]
6. In vitro inhibitory mechanisms and molecular docking of 1'-S-1'-acetoxychavicol acetate on human cytochrome P450 enzymes.
Haque AKMM; Leong KH; Lo YL; Awang K; Nagoor NH
Phytomedicine; 2017 Jul; 31():1-9. PubMed ID: 28606510
[TBL] [Abstract][Full Text] [Related]
7. Inhibition of cytochrome P450 (CYP450) isoforms by isoniazid: potent inhibition of CYP2C19 and CYP3A.
Desta Z; Soukhova NV; Flockhart DA
Antimicrob Agents Chemother; 2001 Feb; 45(2):382-92. PubMed ID: 11158730
[TBL] [Abstract][Full Text] [Related]
8. Characterization of the In Vitro Inhibitory Potential of the Oligonucleotide Imetelstat on Human Cytochrome P450 Enzymes with Predictions of In Vivo Drug-Drug Interactions.
Kazmi F; Sensenhauser C; Greway T
Drug Metab Dispos; 2019 Jan; 47(1):9-14. PubMed ID: 30389730
[TBL] [Abstract][Full Text] [Related]
9. Evaluation of inhibitory effects of caffeic acid and quercetin on human liver cytochrome p450 activities.
Rastogi H; Jana S
Phytother Res; 2014 Dec; 28(12):1873-8. PubMed ID: 25196644
[TBL] [Abstract][Full Text] [Related]
10.
Zhang N; Liu J; Chen Z; Dou W
Pharm Biol; 2019 Dec; 57(1):571-576. PubMed ID: 31456483
[No Abstract] [Full Text] [Related]
11. Exploration of cytochrome P450 inhibition mediated drug-drug interaction potential of kratom alkaloids.
Kamble SH; Sharma A; King TI; Berthold EC; León F; Meyer PKL; Kanumuri SRR; McMahon LR; McCurdy CR; Avery BA
Toxicol Lett; 2020 Feb; 319():148-154. PubMed ID: 31707106
[TBL] [Abstract][Full Text] [Related]
12. In vitro oxidative metabolism of cajaninstilbene Acid by human liver microsomes and hepatocytes: involvement of cytochrome p450 reaction phenotyping, inhibition, and induction studies.
Hua X; Peng X; Tan S; Li C; Wang W; Luo M; Fu Y; Zu Y; Smyth H
J Agric Food Chem; 2014 Oct; 62(43):10604-14. PubMed ID: 25272989
[TBL] [Abstract][Full Text] [Related]
13. Development and Validation of a Higher-Throughput Cytochrome P450 Inhibition Assay with the Novel Cofactor-Supplemented Permeabilized Cryopreserved Human Hepatocytes (MetMax Human Hepatocytes).
Palacharla VRC; Chunduru P; Ajjala DR; Bhyrapuneni G; Nirogi R; Li AP
Drug Metab Dispos; 2019 Oct; 47(10):1032-1039. PubMed ID: 31375472
[TBL] [Abstract][Full Text] [Related]
14. Inhibitory effects of curculigoside on human liver cytochrome P450 enzymes.
Lang J; Li W; Zhao J; Wang K; Chen D
Xenobiotica; 2017 Oct; 47(10):849-855. PubMed ID: 27819189
[TBL] [Abstract][Full Text] [Related]
15. Metabolism of 7-benzyloxy-4-trifluoromethyl-coumarin by human hepatic cytochrome P450 isoforms.
Renwick AB; Surry D; Price RJ; Lake BG; Evans DC
Xenobiotica; 2000 Oct; 30(10):955-69. PubMed ID: 11315104
[TBL] [Abstract][Full Text] [Related]
16. Inhibitory Effects of Triptolide on Human Liver Cytochrome P450 Enzymes and P-Glycoprotein.
Zhang H; Ya G; Rui H
Eur J Drug Metab Pharmacokinet; 2017 Feb; 42(1):89-98. PubMed ID: 26874845
[TBL] [Abstract][Full Text] [Related]
17.
Li M; Liu X; Wang Y; Ju X
Xenobiotica; 2020 Oct; 50(10):1202-1207. PubMed ID: 32338127
[TBL] [Abstract][Full Text] [Related]
18. [Interaction of butylphthalide with rat and human liver CYP450 isoenzymes].
Zhao Q; Hu JP; Jiang J; Li Y; Hu P
Yao Xue Xue Bao; 2015 May; 50(5):541-6. PubMed ID: 26234133
[TBL] [Abstract][Full Text] [Related]
19. Inhibition of human cytochromes P450 in vitro by ritonavir and cobicistat.
Hossain MA; Tran T; Chen T; Mikus G; Greenblatt DJ
J Pharm Pharmacol; 2017 Dec; 69(12):1786-1793. PubMed ID: 28960344
[TBL] [Abstract][Full Text] [Related]
20. Risk assessment of the chiral pesticide fenamiphos in a human model: Cytochrome P450 phenotyping and inhibition studies.
de Albuquerque NCP; Carrão DB; Habenschus MD; Fonseca FS; Moreira da Silva R; Lopes NP; Rocha BA; Barbosa Júnior F; de Oliveira ARM
Food Chem Toxicol; 2020 Dec; 146():111826. PubMed ID: 33127494
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]